Sayet I, Neuilly G, Rakotoarisoa L, Mironneau J, Mironneau C
Laboratoire de Physiologie Cellulaire et Pharmacologie Moléculaire, URA CNRS 1489, Université de Bordeaux II, France.
Eur J Pharmacol. 1993 Aug 15;246(3):275-81. doi: 10.1016/0922-4106(93)90042-8.
We examined which subtypes of alpha 1-adrenoceptors are expressed in rat vena cava by using both functional and [3H]prazosin binding experiments. Pretreatment with chloroethylclonidine inactivated about 80% of the specific [3H]prazosin binding sites and reduced the maximal noradrenaline-induced contraction to the same extent. Competition with subtype-selective agonists and antagonists showed primarily the alpha 1B-adrenoceptor subtype in vena cava. The number of alpha 1-adrenoceptors estimated with [3H]prazosin binding and the maximal noradrenaline-induced contraction were dose-dependently inhibited by phenoxybenzamine, indicating the absence of receptor reserve for noradrenaline in vena cava. As the noradrenaline-induced contraction was largely inhibited in Ca(2+)-free solution, these results suggest that alpha 1B-adrenoceptors can be mainly linked to Ca2+ influx in rat vena cava.
我们通过功能实验和[3H]哌唑嗪结合实验,研究了大鼠腔静脉中表达的α1-肾上腺素能受体的哪些亚型。用氯乙可乐定预处理可使约80%的特异性[3H]哌唑嗪结合位点失活,并使去甲肾上腺素诱导的最大收缩程度降低相同程度。与亚型选择性激动剂和拮抗剂的竞争主要显示腔静脉中的α1B-肾上腺素能受体亚型。用[3H]哌唑嗪结合法估计的α1-肾上腺素能受体数量和去甲肾上腺素诱导的最大收缩,均被酚苄明剂量依赖性抑制,表明腔静脉中去甲肾上腺素不存在受体储备。由于去甲肾上腺素诱导的收缩在无钙溶液中被大大抑制,这些结果表明α1B-肾上腺素能受体在大鼠腔静脉中可能主要与Ca2+内流有关。